Nonlinear Mixed Effect Modeling | List of Frontiers open access articles

Original Research

Published on 08 Dec 2022

Joint population pharmacokinetic modeling of venlafaxine and O-desmethyl venlafaxine in healthy volunteers and patients to evaluate the impact of morbidity and concomitant medication

in Experimental Pharmacology and Drug Discovery

Zhanzhang Wang
Lu Li
Shanqing Huang
Xipei Wang
Shujing Liu
Xiaolin Li
Wan Kong
Xiaojia Ni
Ming Zhang
Shanshan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.978202

5,630 views
7 citations

Systematic Review

Published on 08 Nov 2021

The Effects of L-Carnitine, Acetyl-L-Carnitine, and Propionyl-L-Carnitine on Body Mass in Type 2 Diabetes Mellitus Patients

in Clinical Nutrition

Dong-Dong Wang
Tian-Yun Wang
Yang Yang
Su-Mei He
You-Mei Wang

Frontiers in Nutrition

doi 10.3389/fnut.2021.748075

15,632 views
5 citations

Original Research

Published on 26 Jun 2018

Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations

in Obstetric and Pediatric Pharmacology

Zhi-ling Li
Yi-xi Liu
Zheng Jiao
Gang Qiu
Jian-quan Huang
Yu-bo Xiao
Shu-jin Wu
Chen-yu Wang
Wen-juan Hu
Hua-jun Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00603

7,646 views
30 citations

Original Research

Published on 05 Feb 2021

Population Pharmacokinetics and Exposure–Safety Relationship of Paclitaxel Liposome in Patients With Non-small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Haiyan Zhou
Jiaqing Yan
Wei Chen
Jun Yang
Min Liu
Yuan Zhang
Xin Shen
Yinglin Ma
Xingsheng Hu
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.01731

6,540 views
13 citations

Original Research

Published on 14 Apr 2022

Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients

in Obstetric and Pediatric Pharmacology

Natalia Maximova
Daniela Nisticò
Giacomo Luci
Roberto Simeone
Elisa Piscianz
Ludovica Segat
Egidio Barbi
Antonello Di Paolo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.865871

5,332 views
7 citations

Original Research

Published on 28 Nov 2022

Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients

in Cardiovascular and Smooth Muscle Pharmacology

Dong-Dong Wang
Cun Zhang
Ping Zhu
Su-Mei He
Xiao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.910858

2,771 views

Articles

Joint population pharmacokinetic modeling of venlafaxine and O-desmethyl venlafaxine in healthy volunteers and patients to evaluate the impact of morbidity and concomitant medication

The Effects of L-Carnitine, Acetyl-L-Carnitine, and Propionyl-L-Carnitine on Body Mass in Type 2 Diabetes Mellitus Patients

Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations

Population Pharmacokinetics and Exposure–Safety Relationship of Paclitaxel Liposome in Patients With Non-small Cell Lung Cancer

Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients

Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients